BioNTech SE's total assets for Q4 2024 were €22.53B, an increase of 0.34% from the previous quarter. BNTX total liabilities were €3.12B for the fiscal quarter, a -5.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.